The Senate late Tuesday voted 56-44 to confirm Martin Makary to lead the Food and Drug Administration.
Makary, a former Johns Hopkins University surgeon and author, has been widely seen as a more middle-of-the-road pick compared to Trump’s other choices to lead the Department of Health and Human Services’ subagencies.
He will take over leadership of the agency as the FDA has been targeted by sweeping cuts by Elon Musk’s so-called Department of Government Efficiency. Makary said during his confirmation hearing that he will review recent cuts to the FDA’s workforce.